xefo rapid
takeda pharma a/s, dánsko - lornoxikam - 29 - antirheumatica, antiphlogistica, antiuratica
xefo 8 mg filmom obalené tablety
takeda pharma a/s, dánsko - lornoxikam - 29 - antirheumatica, antiphlogistica, antiuratica
xefo 4 mg filmom obalené tablety
takeda pharma a/s, dánsko - lornoxikam - 29 - antirheumatica, antiphlogistica, antiuratica
xefo 4 mg/ml
takeda pharma a/s, dánsko - lornoxikam - 29 - antirheumatica, antiphlogistica, antiuratica
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedémy, dedičné - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.
alunbrig
takeda pharma a/s - brigatinib - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.
livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovírusové infekcie - antivirotiká na systémové použitie - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). je treba vziať do úvahy oficiálne usmernenie o vhodnom používaní protivírusové agentov.
qdenga
takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - tropická horúčka - vakcíny - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.
firazyr
takeda pharmaceuticals international ag - ikatibant - angioedémy, dedičné - kardioterapia - firazyr je indikovaný na symptomatickú liečbu akútnych záchvatov dedičného angioedému (hae) u dospelých (s deficienciou inhibítora c1-esterázy).
aplikácia mobilná pre pacientov mypkfit
takeda pharmaceuticals u.s.a., inc. 95 hayden avenue ma 02421 lexington spojené štáty americké -